| Buchanan, Adam H |
Geisinger Clinic
United States |
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS |
5U01CA240747-04 |
PAR-18-616 (U01 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
| Buczynski, Matthew Wallace |
Virginia Polytechnic Inst And St Univ
United States |
Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy |
5R01CA284075-02 |
|
Rachel Altshuler, Ph.D. |
| Burgess, Mark Thomas |
Sloan-Kettering Inst Can Research
United States |
Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging |
1R21CA290252-01 |
|
Goli Samimi, Ph.D., M.P.H. |
| Buszczak, Michael |
Ut Southwestern Medical Center
United States |
Developing ribosome biogenesis inhibitors for the prevention of cancer |
1UG3CA290312-01 |
|
Kajal Biswas, Ph.D. |
| Bylund, Carma L. |
University Of Florida
United States |
Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators |
5R01CA253330-03 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Cai, Long |
California Institute Of Technology
United States |
Understanding the role of tumor microenvironment in low grade glioma progression to malignancy |
1U01CA294551-01 |
|
Sidney Fu, M.D. |
| Cantuaria, Guilherme |
Northside Hospital Atlanta
United States |
Georgia NCI Community Oncology Research Program (GA NCORP) |
5UG1CA189997-11 |
|
Vanessa A. White, M.P.H. |
| Cao, Shugeng |
University Of Hawaii At Hilo
United States |
Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors |
1UG3CA290375-01 |
|
Altaf Mohammed, Ph.D. |
| Cao, Lei |
Ohio State University
United States |
Cancer prevention and treatment by activation of a brain-adipocyte axis |
5R01CA166590-10 |
|
Winfred Malone, Ph.D., M.P.H. |
| Cao, Yin |
Washington University
United States |
Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia |
5R37CA246175-05 |
|
Asad Umar, D.V.M., Ph.D. |